anti ccl2 antibody (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
90
Structured Review
R&D Systems
anti ccl2 antibody
Anti Ccl2 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ccl2+antibody/Canine+CCL2%2FJE%2FMCP-1+Antibody/pm41910735-67-17-19
Average 90 stars, based on 8 article reviews
Anti Ccl2 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ccl2+antibody/Canine+CCL2%2FJE%2FMCP-1+Antibody/pm41910735-67-17-19
Average 90 stars, based on 8 article reviews
anti ccl2 antibody - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: B cells mediate lung ischemia/reperfusion injury by recruiting classical monocytes via synergistic B cell receptor/TLR4 signaling Article Snippet: For selected experiments, mice were treated with 25 ng Article Title: B cells mediate lung ischemia/reperfusion injury by recruiting classical monocytes via synergistic B cell receptor/TLR4 signaling Article Snippet: For selected experiments, mice were treated with 25 ng Recombinant:Article Title: Human 3D Ovarian Cancer Models Reveal Malignant Cell–Intrinsic and –Extrinsic Factors That Influence CAR T-cell Activity Article Snippet: .. Target cell and CAR T-cell cultures were treated with 0 to 25 μg/mL of pembrolizumab (Merck), 1 μmol/L of birinapant TL32711 (Selleckchem, Cat. S7015), 5 ng/mL recombinant CCL2 (R&D Systems, Cat. 279-MC-010), 5 μg/mL In Vivo:Article Title: Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy Article Snippet: 1 Repolarization of immunosuppressive macrophages by targeting SLAMF7regulated CCL2 signaling sensitizes hepatocellular carcinoma to immunotherapy Jialei Weng 1,2,† , Zheng Wang 3,† , Zhiqiu Hu 4,5,† , Wenxin Xu 1 , Jia-Lei Sun 6 , Fu Wang 6 , Qiang Zhou 1,2 , Shaoqing Liu 1,2 , Min Xu 1,2 , Minghao Xu 1,2 , Dongmei Gao 1 , Ying-Hao Shen 1 , Yong Yi 1 , Yi Shi 7 , Qiongzhu Dong 2,4 , Chenhao Zhou 1,2,* , and Ning Ren 1,2,4,* 1 Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, 200032, P.R.. China.. 2 Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer of Shanghai Municipal Health Commission, Shanghai, 201199, P.R. Injection:Article Title: Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy Article Snippet: 1 Repolarization of immunosuppressive macrophages by targeting SLAMF7regulated CCL2 signaling sensitizes hepatocellular carcinoma to immunotherapy Jialei Weng 1,2,† , Zheng Wang 3,† , Zhiqiu Hu 4,5,† , Wenxin Xu 1 , Jia-Lei Sun 6 , Fu Wang 6 , Qiang Zhou 1,2 , Shaoqing Liu 1,2 , Min Xu 1,2 , Minghao Xu 1,2 , Dongmei Gao 1 , Ying-Hao Shen 1 , Yong Yi 1 , Yi Shi 7 , Qiongzhu Dong 2,4 , Chenhao Zhou 1,2,* , and Ning Ren 1,2,4,* 1 Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, 200032, P.R.. China.. 2 Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer of Shanghai Municipal Health Commission, Shanghai, 201199, P.R. Control:Article Title: Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy Article Snippet: 1 Repolarization of immunosuppressive macrophages by targeting SLAMF7regulated CCL2 signaling sensitizes hepatocellular carcinoma to immunotherapy Jialei Weng 1,2,† , Zheng Wang 3,† , Zhiqiu Hu 4,5,† , Wenxin Xu 1 , Jia-Lei Sun 6 , Fu Wang 6 , Qiang Zhou 1,2 , Shaoqing Liu 1,2 , Min Xu 1,2 , Minghao Xu 1,2 , Dongmei Gao 1 , Ying-Hao Shen 1 , Yong Yi 1 , Yi Shi 7 , Qiongzhu Dong 2,4 , Chenhao Zhou 1,2,* , and Ning Ren 1,2,4,* 1 Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, 200032, P.R.. China.. 2 Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer of Shanghai Municipal Health Commission, Shanghai, 201199, P.R. Concentration Assay:Article Title: ALKBH5 facilitates Srgn stability via m6A demethylation to disrupt blood-testis barrier integrity in the high-fat diet mice. Article Snippet: Cells were transfected with plasmids or siRNAs using Lipofectamine 3000 reagent (Invitrogen; Thermo Fisher Scientific, Inc.) following the manufacturer's instructions after being seeded in a dish and cultured for 24 h. The transfection efficiency was evaluated after 24–72 h. The siRNA sequences used in this study were as follows: siAlkbh5-1: 5′ - CACCGCGAUUGGAAACAAATT- 3′, siAlkbh5-2: 5′- GCUGCAAGUUCCAGUUCATT - 3′; siSrgn-1: 5′ - GGATCTTCAGTGCAAGGTT - 3′, siSrgn-2: 5′ - GACCACAGTTTGACCTAAT - 3′, siSrgn-3: 5′ - CCAACAGATGAAAGCAATA - 3′. .. Following the instructions provided in the reagent manual, the TM4 and primary Sertoli cells were treated with Blocking Assay:Article Title: Hydrophobic surface induced pro-metastatic cancer cells for in vitro extravasation models Article Snippet: After processing the images with ZEN (Carl Zeiss) or ImageJ software, the fully-extravasated or non-extravasated SKOV3 cells were counted over the entire chip and the extravasation percentage was quantified. .. For blocking CCL2-CCR2 binding interactions, the cancer cell suspensions were supplemented with Article Title: Cooperation between ZEB2 and SP1 upregulates PD-L1 and CCL2 to promote the immunosuppressive activity of tumor cells Article Snippet: .. The cells were allowed to migrate for 24 h. Where indicated, an Binding Assay:Article Title: Hydrophobic surface induced pro-metastatic cancer cells for in vitro extravasation models Article Snippet: After processing the images with ZEN (Carl Zeiss) or ImageJ software, the fully-extravasated or non-extravasated SKOV3 cells were counted over the entire chip and the extravasation percentage was quantified. .. For blocking CCL2-CCR2 binding interactions, the cancer cell suspensions were supplemented with Activity Assay:Article Title: Cooperation between ZEB2 and SP1 upregulates PD-L1 and CCL2 to promote the immunosuppressive activity of tumor cells Article Snippet: .. The cells were allowed to migrate for 24 h. Where indicated, an |
